<DOC>
	<DOCNO>NCT02451475</DOCNO>
	<brief_summary>Background : The investigator hypothesize combined use pregabalin paroxetine would associate comparable Somatic Symptoms Scale-8 ( SSS-8 ) high tolerability amitriptyline venlafaxine . Methods : After ethical approval , 75 patient diagnosed fibromyalgia receive pregabalin 75 mg/day , randomly allocate receive amitriptyline 25 mg/day ( n = 24 ) , venlafaxine 75 mg/day ( n = 25 ) , paroxetine 25 mg/day ( n = 26 ) . All patient assess bi-monthly consequent six month change SSS-8 , Center Epidemiological Studies Depression Scale ( CESDS ) , life satisfaction , mood , sleep quality , fatigue medication tolerability adverse effect .</brief_summary>
	<brief_title>Newer Antidepressants Combination With Pregabalin Fibromyalgia Syndrome</brief_title>
	<detailed_description>Fibromyalgia common cause chronic widespread disable pain affect 2-5 % young middle-aged woman develop country . The American College Rheumatology establish new diagnostic criterion fibromyalgia 2010 include widespread pain index ( WPI ) categorical scale cognitive symptom , unrefreshed sleep , fatigue , number somatic symptom . The definite pathophysiology chronic pain fibromyalgia remain unclear . Fibromyalgia usually associate depression , anxiety , alexithymia increase age contribute significantly reduce patient wellbeing . These may due alteration central pain pathway , hyporeactivity hypothalamus-pituitary-adrenal axis , disturbances dopaminergic serotonergic system . Thus European League Against Rheumatism ( EULAR ) recommend use serotonin noradrenaline reuptake inhibitor ( SNRIs ) treatment fibromyalgia , reduce pain improve function . However , patient achieve satisfactory pain relief sole use SNRIs . A recent Cochrane review demonstrate modest improvement relieve pain without reduce sleep disturbance , fatigue , poor quality life use duloxetine milnacipran placebo patient fibromyalgia . More patient experienced adverse event like nausea , dry mouth , constipation , headache , somnolence , dizziness insomnia lead stop medication . Whereas , evidence clinical study show combine use pregabalin SNRIs duloxetine potential efficacy well tolerability treatment improvement pain , fatigue , sleep disorder patient fibromyalgia . The use second-generation antidepressant like paroxetine ( selective serotonin reuptake inhibitor ( SSRIs ) ) venlafaxine ( SNRIs ) may associate tolerability reduce pain patient major depressive disorder . To best investigator 's knowledge , comparison long-term efficacy , tolerability , safety combine use pregabalin one three antidepressant , namely , amitriptyline , venlafaxine , paroxetine treatment fibromyalgia yet study . The investigator hypothesize combined use pregabalin paroxetine would associate comparable Somatic Symptoms Scale-8 ( SSS-8 ) Center Epidemiological Studies Depression scale ( CESD ) high tolerability use pregabalin either amitriptyline venlafaxine .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<criteria>Fibromyalgia Receiving pregabalin daily Pathologies mimic symptom fibromyalgia Acute systemic inflammatory disease Infections Pregnancy Lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Pregabalin</keyword>
	<keyword>Fibromyalgia</keyword>
</DOC>